Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Leslie J Williams
AddedMar 31, 2024
UpdatedMay 31, 2026
Leslie J Williams

Leslie J Williams

Board Member, Ocular Therapeutix

CrunchbaseLinkedIn

Leslie J Williams's Career

Ocular Therapeutix
Ocular Therapeutix

Bedford, MA, US

Board Member· Board
Windtree Therapeutics
Windtree Therapeutics

Warrington, PA, US

Board Member· Board
ImmusanT
ImmusanT

Cambridge, MA, US

Founder
hC Bioscience
hC Bioscience

Cambridge, MA, US

Board Member· Board
CDI Bioscience
CDI Bioscience

Madison, WI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Leslie J Williams's Career

Ocular Therapeutix
Ocular Therapeutix
Public$386.5M2742006Bedford, MA, US
Board Member· Board

Leadership at Ocular Therapeutix

Antony MattessichAntony MattessichBoard Member
Merilee RainesMerilee RainesBoard Member
Amarpreet SawhneyAmarpreet SawhneyCo-Founder
Fred KhosraviFred KhosraviCo-Founder
Charles WardenCharles WardenBoard Member
Richard L LindstromRichard L LindstromBoard Member

Similar to Ocular Therapeutix

OcuCure TherapeuticsOcuCure TherapeuticsRoanoke, VA, USEye Drops, Pharmaceuticalsest. 2005OcuCure TherapeuticsRoanoke, VA, US · est. 2005

OcuCure Therapeutics: Developing innovative eye drops for age-related and diabetic eye diseases since 2005.

Public · $3.3M8
EyeCyteEyeCyteLos Angeles, CA, USTherapeuticsest. 2005EyeCyteLos Angeles, CA, US · est. 2005

EyeCyte: Developing novel therapeutics for neovascular and degenerative retinal diseases.

Series A · $3M5
Windtree Therapeutics
Windtree Therapeutics
Public$138.9M331992Warrington, PA, US
Board Member· Board

Leadership at Windtree Therapeutics

Rob ScottRob ScottBoard Member
Masa NakatsuMasa NakatsuFounder
James HuangJames HuangBoard Member
Dan GeffkenDan GeffkenBoard Member
Craig E FraserCraig E FraserBoard Member

Similar to Windtree Therapeutics

PulmatrixPulmatrixLexington, MA, USTherapeuticsest. 2003PulmatrixLexington, MA, US · est. 2003

Pulmatrix, Inc.: A US-based biotech firm specializing in therapies for chronic respiratory diseases.

Public · $148.4M24
PineTree TherapeuticsPineTree TherapeuticsCambridge, MA, USBiotech Therapiesest. 2019PineTree TherapeuticsCambridge, MA, US · est. 2019

PineTree Therapeutics: Innovating biotech therapies in Oncology and Immuno-oncology.

Series B · $23.5M17
Windgap MedicalWindgap MedicalWatertown, MA, USHealthcare Productsest. 2011Windgap MedicalWatertown, MA, US · est. 2011

Windgap Medical, Inc.: Biotech firm specializing in allergy treatment healthcare products.

Public · $42M47
Window TherapeuticsWindow TherapeuticsBoston, MA, USCancer Treatmentest. 2021Window TherapeuticsBoston, MA, US · est. 2021

Window Therapeutics: A biotech firm innovating targeted cancer treatments for unmet patient needs.

Angel · $256k4
ImmusanT
ImmusanT
Acquired$72.8M02011Cambridge, MA, US
Founder

Leadership at ImmusanT

Thomas DanielThomas DanielBoard Member
Thomas KoestlerThomas KoestlerBoard Member
hC Bioscience
hC Bioscience

Cambridge, MA, US

Board Member· Board
CDI Bioscience
CDI Bioscience

Madison, WI, US

Board Member· Board

Leslie J Williams's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Leslie J Williams

Jay YuJay YuBoard Member · Test DiagnosticsWilliam A. Callahan, CFAWilliam A. Callahan, CFAFounder · ResearchlyGlenn LaubGlenn LaubCo-Founder · Ventis MedicalColin FosterColin FosterBoard Member · Ontario Bioscience Industry OrganizationDoug BaldwinDoug BaldwinCEO · VentrkCarl SchlachteCarl SchlachteBoard Member · Ventiva